Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes R Hov

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Gut|July 18, 2024
Sclerosing cholangitis and inflammatory bowel disease: a paradoxical relationship?Johannes R Hov
Alimentary Pharmacology & Therapeutics|December 24, 2022
Editorial: dietary interventions to understand and treat primary sclerosing cholangitis-is gluten-free diet a starting point?Johannes R Hov
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2019
The gut microbial influence on cholestatic liver diseaseMartin Kummen, Johannes R Hov
Current Opinion in Gastroenterology|December 29, 2016
Intestinal microbiota in primary sclerosing cholangitisJohannes R Hov, Martin Kummen
Gut|June 25, 2016
Response to 'Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis' by Rühlemann <i>et al</i>Martin Kummen, Johannes R Hov
Nature Reviews. Gastroenterology & Hepatology|November 9, 2022
The microbiota and the gut-liver axis in primary sclerosing cholangitisJohannes R Hov, Tom H Karlsen
Journal of Hepatology|November 6, 2025
Phase II clinical trials in primary sclerosing cholangitis: Making the most of every opportunity?David N Assis, Johannes R Hov
Current Opinion in Gastroenterology|January 1, 2010
Genetics of cholestatic liver disease in 2010Tom H Karlsen, Johannes R Hov
Seminars in Liver Disease|December 23, 2017
The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential ConceptsJohannes R Hov, Tom H Karlsen
Circulation. Heart Failure|December 16, 2022
Phenylacetylglutamine From the Gut Microbiota: A Future Therapeutic Target in Heart Failure?Ayodeji Awoyemi, Johannes R Hov, Marius Trøseid
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Gut|July 18, 2024
Sclerosing cholangitis and inflammatory bowel disease: a paradoxical relationship?Johannes R Hov
Alimentary Pharmacology & Therapeutics|December 24, 2022
Editorial: dietary interventions to understand and treat primary sclerosing cholangitis-is gluten-free diet a starting point?Johannes R Hov
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2019
The gut microbial influence on cholestatic liver diseaseMartin Kummen, Johannes R Hov
Current Opinion in Gastroenterology|December 29, 2016
Intestinal microbiota in primary sclerosing cholangitisJohannes R Hov, Martin Kummen
Gut|June 25, 2016
Response to 'Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis' by Rühlemann <i>et al</i>Martin Kummen, Johannes R Hov
Nature Reviews. Gastroenterology & Hepatology|November 9, 2022
The microbiota and the gut-liver axis in primary sclerosing cholangitisJohannes R Hov, Tom H Karlsen
Journal of Hepatology|November 6, 2025
Phase II clinical trials in primary sclerosing cholangitis: Making the most of every opportunity?David N Assis, Johannes R Hov
Current Opinion in Gastroenterology|January 1, 2010
Genetics of cholestatic liver disease in 2010Tom H Karlsen, Johannes R Hov
Seminars in Liver Disease|December 23, 2017
The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential ConceptsJohannes R Hov, Tom H Karlsen
Circulation. Heart Failure|December 16, 2022
Phenylacetylglutamine From the Gut Microbiota: A Future Therapeutic Target in Heart Failure?Ayodeji Awoyemi, Johannes R Hov, Marius Trøseid
Pageof 12